
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Gut butyrate-producers confer post-infarction cardiac protection
Hung-Chih Chen, Yen-Wen Liu, Kuan‐Cheng Chang, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 25
Hung-Chih Chen, Yen-Wen Liu, Kuan‐Cheng Chang, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 25
Showing 25 citing articles:
Short‐Chain Fatty Acid Butyrate Is an Inotropic Agent With Vasorelaxant and Cardioprotective Properties
Jacob Marthinsen Seefeldt, Casper Homilius, Jakob Hansen, et al.
Journal of the American Heart Association (2024) Vol. 13, Iss. 9
Open Access | Times Cited: 12
Jacob Marthinsen Seefeldt, Casper Homilius, Jakob Hansen, et al.
Journal of the American Heart Association (2024) Vol. 13, Iss. 9
Open Access | Times Cited: 12
Advancing lifelong precision medicine for cardiovascular diseases through gut microbiota modulation
Bozhong Shi, Haoyu Li, Xiaomin He
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 10
Bozhong Shi, Haoyu Li, Xiaomin He
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 10
Recent progresses in gut microbiome mediates obstructive sleep apnea‐induced cardiovascular diseases
Xiaotong Zhang, Zhang Hai-fen, Shuai Cheng Li, et al.
FASEB BioAdvances (2024) Vol. 6, Iss. 4, pp. 118-130
Open Access | Times Cited: 5
Xiaotong Zhang, Zhang Hai-fen, Shuai Cheng Li, et al.
FASEB BioAdvances (2024) Vol. 6, Iss. 4, pp. 118-130
Open Access | Times Cited: 5
Unveiling the microbiota-metabolite-myocardium axis: a novel perspective on cardiovascular health
Zhenhua Guo, Yangfang Zhong, Le Zhou, et al.
Frontiers in Microbiology (2024) Vol. 15
Open Access | Times Cited: 5
Zhenhua Guo, Yangfang Zhong, Le Zhou, et al.
Frontiers in Microbiology (2024) Vol. 15
Open Access | Times Cited: 5
Intestinal mucosal barrier: a potential target for traditional Chinese medicine in the treatment of cardiovascular diseases
Jiahui Liu, Xiunan Wei, Tong Wang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 4
Jiahui Liu, Xiunan Wei, Tong Wang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 4
D-beta-hydroxybutyrate up-regulates Claudin-1 and alleviates the intestinal hyperpermeability in lipopolysaccharide-treated mice
Ting Wang, Yuchen Zhuang, Chenglong Yu, et al.
Tissue and Cell (2024) Vol. 87, pp. 102343-102343
Closed Access | Times Cited: 4
Ting Wang, Yuchen Zhuang, Chenglong Yu, et al.
Tissue and Cell (2024) Vol. 87, pp. 102343-102343
Closed Access | Times Cited: 4
Indole-3-Propionic Acid, a Gut Microbiota-Derived Tryptophan Metabolite, Promotes Endothelial Dysfunction Impairing Purinergic-Induced Nitric Oxide Release in Endothelial Cells
Federica Geddo, Susanna Antoniotti, Maria Pia Gallo, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 6, pp. 3389-3389
Open Access | Times Cited: 4
Federica Geddo, Susanna Antoniotti, Maria Pia Gallo, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 6, pp. 3389-3389
Open Access | Times Cited: 4
Effects of antibiotic therapy on the early development of gut microbiota and butyrate-producers in early infants
Jun Qiu, Sha Wu, Ruiwen Huang, et al.
Frontiers in Microbiology (2025) Vol. 15
Open Access
Jun Qiu, Sha Wu, Ruiwen Huang, et al.
Frontiers in Microbiology (2025) Vol. 15
Open Access
Lactobacillus gasseri prevents ibrutinib-associated atrial fibrillation through butyrate
Ling Shi, Yu Duan, Ning Fang, et al.
EP Europace (2025)
Closed Access
Ling Shi, Yu Duan, Ning Fang, et al.
EP Europace (2025)
Closed Access
Maladaptive Peripheral Ketogenesis in Schwann Cells Mediated by CB1R Contributes to Diabetic Neuropathy
Weizhen Li, Tuo Yang, Ningning Wang, et al.
Advanced Science (2025)
Open Access
Weizhen Li, Tuo Yang, Ningning Wang, et al.
Advanced Science (2025)
Open Access
Butyrate-engineered yeast activates Nppa and Sgcg genes and reduces radiation-induced heart damage via the gut-heart axis
Jiahao Wu, Kaihua Ji, Guangbo Kang, et al.
Pharmacological Research (2025), pp. 107642-107642
Open Access
Jiahao Wu, Kaihua Ji, Guangbo Kang, et al.
Pharmacological Research (2025), pp. 107642-107642
Open Access
Short-Chain Fatty Acids and Their Metabolic Interactions in Heart Failure
Laura Chulenbayeva, Argul Issilbayeva, Aliya Sailybayeva, et al.
Biomedicines (2025) Vol. 13, Iss. 2, pp. 343-343
Open Access
Laura Chulenbayeva, Argul Issilbayeva, Aliya Sailybayeva, et al.
Biomedicines (2025) Vol. 13, Iss. 2, pp. 343-343
Open Access
Hyperglycemia-Driven Hepatic Immune Dysfunction Facilitates Microbial Dissemination Post-Myocardial Infarction
Tony Tang, Subur P. Pasaribu, Hung-Chih Chen, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access
Tony Tang, Subur P. Pasaribu, Hung-Chih Chen, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access
Targeting gut-immune-heart modulate cardiac remodeling after acute myocardial infarction
Jinmei Yu, Lin Zhou, Guo Li, et al.
Life Sciences (2025), pp. 123606-123606
Open Access
Jinmei Yu, Lin Zhou, Guo Li, et al.
Life Sciences (2025), pp. 123606-123606
Open Access
Hesperidin improves cardiac fibrosis induced by β-adrenergic activation through modulation of gut microbiota
Xia Liu, Weiwei Ju, Erjiao Qiang, et al.
Journal of Pharmacology and Experimental Therapeutics (2025), pp. 103578-103578
Closed Access
Xia Liu, Weiwei Ju, Erjiao Qiang, et al.
Journal of Pharmacology and Experimental Therapeutics (2025), pp. 103578-103578
Closed Access
Time-restricted feeding protects against septic liver injury by reshaping gut microbiota and metabolite 3-hydroxybutyrate
Jingjuan Hu, Fan Deng, Qi‐Shun Sun, et al.
Gut Microbes (2025) Vol. 17, Iss. 1
Open Access
Jingjuan Hu, Fan Deng, Qi‐Shun Sun, et al.
Gut Microbes (2025) Vol. 17, Iss. 1
Open Access
Microbial metabolites associated in stool and left ventricle of heart failure patients revealed by meta-analysis
Emily Wissel, Hsin-Yuan Chien, Ke-Hsuan Wei, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Emily Wissel, Hsin-Yuan Chien, Ke-Hsuan Wei, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Evidence further linking the intestine to cardiovascular disease
Dawoud Sulaiman, Srinivasa T. Reddy, Alan M. Fogelman
Current Opinion in Lipidology (2024) Vol. 35, Iss. 5, pp. 223-227
Open Access | Times Cited: 3
Dawoud Sulaiman, Srinivasa T. Reddy, Alan M. Fogelman
Current Opinion in Lipidology (2024) Vol. 35, Iss. 5, pp. 223-227
Open Access | Times Cited: 3
Identification of components from Aralia elata and their effects on muscle health and gut microbiota
Hyejin Ko, T. Bekele, Tam Thi Le, et al.
Journal of Functional Foods (2024) Vol. 121, pp. 106384-106384
Open Access | Times Cited: 2
Hyejin Ko, T. Bekele, Tam Thi Le, et al.
Journal of Functional Foods (2024) Vol. 121, pp. 106384-106384
Open Access | Times Cited: 2
The Gut Microbiota Mediates the Protective Effects of Spironolactone on Myocardial Infarction
Lu Li, Jianyong Sun, Yulin Li, et al.
The Journal of Microbiology (2024)
Closed Access | Times Cited: 1
Lu Li, Jianyong Sun, Yulin Li, et al.
The Journal of Microbiology (2024)
Closed Access | Times Cited: 1
Butyrate-Mediated Modulation of Paraoxonase-1 Alleviates Cardiorenometabolic Abnormalities in a Rat Model of Polycystic Ovarian Syndrome
Kehinde S. Olaniyi, Stephanie E. Areloegbe, Olabimpe C. Badejogbin, et al.
Cardiovascular Drugs and Therapy (2024)
Closed Access | Times Cited: 1
Kehinde S. Olaniyi, Stephanie E. Areloegbe, Olabimpe C. Badejogbin, et al.
Cardiovascular Drugs and Therapy (2024)
Closed Access | Times Cited: 1
GUT MICROBIOTA METABOLITES AND HOLTER ECG MONITORING IN CORONARY ARTERY DISEASE PATIENTS WITH ATRIAL FIBRILLATION
I.O. Melnychuk
Art of Medicine (2024), pp. 99-107
Open Access
I.O. Melnychuk
Art of Medicine (2024), pp. 99-107
Open Access
Prediction of symptomatic and asymptomatic bacteriuria in spinal cord injury patients using machine learning
M. Mozammel Hoque, Parisa Noorian, Gustavo Espinoza-Vergara, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
M. Mozammel Hoque, Parisa Noorian, Gustavo Espinoza-Vergara, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Underlying mechanisms of ketotherapy in heart failure: current evidence for clinical implementations
K. Liu, Yang Yang, Jinghua Yang
Frontiers in Pharmacology (2024) Vol. 15
Open Access
K. Liu, Yang Yang, Jinghua Yang
Frontiers in Pharmacology (2024) Vol. 15
Open Access
Allergen-specific sublingual immunotherapy altered gut microbiota in patients with allergic rhinitis
Jing Wu, Dan Wang, Wenjun He, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access
Jing Wu, Dan Wang, Wenjun He, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access